AgingResearch.NewsJoin free

Hokkaido University

OrganisationROR

Trials

Sources: trialsearch.who.int

Grants and prizes

  • Japan Society for the Promotion of Science

    Grant-in-Aid for JSPS Fellows, Elucidation of the secretion mechanism of GLP-1 mediated by intestinal distension, and its application in food products, 26KJ0448, JP¥1.6m, 2026–2028, 22 Apr 2026

  • Japan Society for the Promotion of Science

    Grant-in-Aid for Early-Career Scientists, Application of metformin to wound healing: evaluation of its suppressive effect on burn wound conversion, 26K20123, JP¥4.6m, 2026–2028, 1 Apr 2026

  • Japan Society for the Promotion of Science

    Grant-in-Aid for JSPS Fellows, Regulation of Sensory–Immune Interactions by Exercise-Induced Cellular Senescence, 26KJ0013, JP¥3.5m, 2026–2029, 1 Apr 2026

  • Japan Society for the Promotion of Science

    Grant-in-Aid for Scientific Research (C), Individualized rehabilitation for postoperative elderly patients with musculoskeletal disorders: Development of a predicting method for prognosis using brain MRI, 25K14372, JP¥4.7m, 2025–2028, 1 Apr 2025

  • Japan Society for the Promotion of Science

    Grant-in-Aid for Scientific Research (C), Effect of genetic testing for potential risk of hypertension, diabetes, and dementia on health behaviors, 25K14955, JP¥4.7m, 2025–2028, 1 Apr 2025

  • Japan Society for the Promotion of Science

    Grant-in-Aid for Scientific Research (B), Verification of the effect of oral frailty countermeasures on healthy life expectancy through collaboration between medical care, health, and nursing care prevention, 25K02834, JP¥18.6m, 2025–2030, 1 Apr 2025

  • Japan Society for the Promotion of Science

    Grant-in-Aid for Scientific Research (A), Age-related development of urinary tract-associated lymphoid tissue as a driver of chronic kidney inflammation, 25H00957, JP¥46.3m, 2025–2029, 1 Apr 2025

  • Japan Society for the Promotion of Science

    Grant-in-Aid for Early-Career Scientists, Development of a Novel Treatment for Pancreatic Cancer Cachexia through Metformin-Mediated Reprogramming of Cancer-Associated Myeloid Cells, 25K19753, JP¥4.8m, 2025–2028, 1 Apr 2025

Sources: openalex.org